Clinical Outcomes after Liver Transplantation for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis

Table 1

Characteristic of including studies.

Authors	Year	Country	IAC criteria	Type of study	Period of study	Donor type	N	Age	MELD	Cr
Briceño et al. [13]	2011	Spain	1996 & 2007	Retrospective	1995–2008	DDLT	66	51	25	2.1
Boyer et al. [14]	2011	USA, Germany	1996	RCT	NA	DDLT	35	NA	32	NA
Cassinello et al. [15]	2003	Spain	1996	Prospective	NA	DDLT	10	46	NA	2.2
Chok et al. [16]	2012	Hong Kong	1996 & 2007	Prospective	1997–2007	LDLT	33	52	43	2.8
Goldaracena et al. [17]	2014	Canada	2007	Prospective	2000–2012	DDLT, LDLT	120	52	32	2.9
Lee et al. [18]	2012	Korea	1996	Retrospective	2000–2010	DDLT, LDLT	71	50	38	3.0
Marik et al. [19]	2006	USA	1996	Prospective	2001–2004	DDLT, LDLT	28	51	30	2.9
Nadim et al. [20]	2012	USA	1996	Retrospective	2002–2006	DDLT	35	50	40	NA
Park et al. [21]	2010	Korea	2007	Prospective	2005–2008	DDLT	8	46	33	3.2
Park et al. [22]	2015	Korea	1996	Retrospective	2005–2012	DDLT, LDLT	76	52	38	3.0
Restuccia et al. [23]	2004	Spain	1996	Prospective	1996–2010	DDLT	9	50	NA	2.7
Rice et al. [24]	2011	USA	2007	Retrospective	1997–2004	DDLT	43	53	32	NA
Rodriguez et al. [25]	2015	Spain	1996	Retrospective	1998–2014	DDLT	31	58	21	1.8
Ruiz et al. [26]	2006	USA	1996	Retrospective	1988–2004	DDLT	80	49	26	NA
Ruiz et al. [27]	2007	USA	1996	Prospective	1995–2004	DDLT	130	49	34	NA
Shusterman et al. [28]	2007	USA	1996	Retrospective	1999–2005	DDLT	17	47	NA	NA
Tan et al. [29]	2015	Canada	2007	Retrospective	2000–2012	DDLT	42	58	21	1.8
Wong et al. [7]	2015	Canada	2007	Retrospective	2001–2010	DDLT	62	55	35	3.3
Xing et al. [30]	2013	China	1996	Prospective	2001–2009	DDLT	18	46	25	2.8
Xu et al. [31]	2009	China	1996	Prospective	2003–2006	DDLT	21	47	33	3

IAC: International Ascites Club; N: number; DDLT: deceased donor liver transplantation; LDLT: living donor liver transplantation; NA: non-applicable. Age: expressed as mean. MELD: model of end stage liver disease, expressed as mean. Cr: creatinine, expressed as mean (mg/dL).